Lexis Practice Advisor®Free Trial
Register to request a downloadable copy
Learn More AboutLexis Practice Advisor®
By: Mark S. Bergman, Paul, Weiss, Rifkind, Wharton & Garrison LLP
This article discusses the joint Public Statement1 issued by the U.S. Securities and Exchange Commission (the SEC) Chairman Jay Clayton, SEC Division of Corporation Finance Director Bill Hinman, SEC Chief Accountant Sagar Teotia and PCAOB Chairman William D. Duhnke III (the Statement), addressing financial reporting considerations and potential SEC relief in light of the current and potential effects of the coronavirus.
The Statement follows coronavirus-related comments provided by Clayton in his speech on January 30.2 At that time, Clayton noted that the SEC staff would monitor coronavirus-related developments and provide guidance to companies and other market participants regarding any required disclosures relating to reporting companies’ potential exposure to the effects of the coronavirus and the impact of such exposure on financial disclosures and audit quality. Clayton also noted that, despite the uncertainty surrounding the impact of the coronavirus, how reporting companies plan for the uncertainty and how they respond to events as they evolve can be material to an investment decision.
As noted in the Statement, the coronavirus effects may be of significance to a number of SEC reporting companies (including those based in the United States, in China or elsewhere in the world) that have business operations, or depend on companies (for example, suppliers, distributors and/or customers) that have operations, in China or other countries affected by the virus. As the situation continues to develop, its effects on individual reporting companies remain “difficult to assess or predict with meaningful precision” due to existence of a number of factors beyond their control and knowledge.
From the perspective of a reporting company, the coronavirus may have a range of effects on operations, internal processes and controls, and operating results. There may be administrative challenges for reporting companies with a calendar year-end that could affect audit quality and the timeliness of the completion of the annual audit (e.g., access by auditors to information and company personnel). There may well also be challenges for reporting companies as they prepare disclosures to be included in annual or quarterly reports on Form 10-K or Form 10-Q, or annual reports on Form 20-F or Form 40-F, due to the difficulty in quantifying how they will need to respond to the consequences of the coronavirus as it continues to spread, and quantifying the impact of such consequences, as well as any mitigating actions, on prospects, financial condition, results of operations and cash flows. These consequences will also need to be factored into decisions made around financial reporting (accounting conclusions and reporting/recognition of subsequent events). Access to financial and other information from equity method investees and acquired/to be acquired businesses, as well as from consolidated entities, affected by the coronavirus may also be impacted. Finally, reporting companies headquartered, or with operations, in China, or with supply chain or other material relationships with companies in China, may need to consider the impact of coronavirus consequences on their disclosure controls and procedures and (particularly if controls need to be modified or temporarily replaced) internal control over financial reporting.
As result of the uncertainty, the SEC urges reporting companies to engage with their audit committees and auditors to ensure that “their financial reporting, auditing and review processes are as robust as practicable in light of the circumstances” as this will enable them to better respond to events as they unfold and to meet any applicable requirements. In particular:
The SEC staff expects to engage with registrants on questions they may have in relation to reporting of the potential effects of the coronavirus and encourages reporting companies to contact the SEC staff if they require specific relief or guidance. Based on the circumstances and on the continued monitoring of coronavirus-related developments, the SEC staff will decide whether it would be appropriate to provide relief or additional guidance on a case-by-case or broader basis. In the absence of such relief, reporting companies will only have the limited extensions available as provided in, and upon compliance with, Rule 12b-25 under the Exchange Act.
Mark S. Bergman is co-head of the Global Securities and Capital Markets Group at Paul, Weiss, Rifkind, Wharton & Garrison LLP and is resident in the London office. Mr. Bergman has extensive experience in corporate finance and securities transactions. Offerings in which he has been involved range from traditional offerings of equity and debt (including high yield instruments) to offerings of structured finance products and hybrid securities, principally for financial institutions. He has been involved in global capital markets transactions and other securities offerings for issuers in a number of countries. Among other offerings, he represented the underwriters on the first direct listing by a Chinese company in the United States, and has represented issuers issuing and listing securities on the NYSE, Nasdaq, the London Stock Exchange, the ASX, the Frankfurt Stock Exchange, the Hong Kong Stock Exchange, the Johannesburg Stock Exchange, the Luxembourg Stock Exchange, and the SIX Swiss Exchange. Mr. Bergman is recognized for his work in capital markets transactions by The Legal Media Group Guides to the World’s Leading Capital Markets Lawyers and in The Legal 500. As part of the firm’s general representation of U.S. and non-U.S. companies listed in the United States, Mr. Bergman advises a range of listed companies on reporting and other obligations under the securities laws, establishment of corporate compliance programs, and compliance with corporate governance standards under the securities laws and stock exchange rules. He has advised companies in connection with SEC and other U.S. regulatory investigations, and stock exchange proceedings.
To find this article in Lexis Practice Advisor, follow this research path:
RESEARCH PATH: Capital Markets & Corporate Governance > Trends and Insights > First Analysis > Articles
For practical guidance on the coronavirus in a number of practice areas, see
> CORONAVIRUS (COVID-19) RESOURCE KIT
RESEARCH PATH: Capital Markets & Corporate Governance and Compliance Requirements for Public Companies > Corporate Governance > Practice Notes
For a discussion of corporate financial performance during the coronavirus crisis, see
> CORONAVIRUS AND CORPORATE FINANCIAL PERFORMANCE
RESEARCH PATH: Capital Markets & Corporate Governance > Trends & Insights > First Analysis > Articles
For an overview of disclosure requirements for companies listed on a national securities exchange, see
For an overview of corporate reporting obligations, see
> PERIODIC AND CURRENT REPORTING RESOURCE KIT
RESEARCH PATH: Capital Markets & Corporate Governance > Public Company Reporting > Periodic Reports > Practice Notes
For practice points for attorneys on planning and preparing reports, see
> TOP 10 PRACTICE TIPS: PERIODIC AND CURRENT PUBLIC COMPANY REPORTING
1. https://www.sec.gov/news/public-statement/statement-audit-quality-china-2020-02-19 2. https://www.sec.gov/news/public-statement/clayton-mda-2020-01-30 3. https://www.sec.gov/news/press-release/2018-237 4. https://www.sec.gov/rules/other/2018/ 34-84440.pdf 5. https://www.sec.gov/rules/interim/2018/33-10567.pdf